Type
- ARTG (87)
- Cancellation by sponsor (27)
- Prescription medicine registration (14)
- Australian Public Assessment Report (AusPAR) (11)
- Prescription medicine evaluation (4)
- Section 14, TGO91 consent (3)
- Prescription medicine decision summary (2)
- Cancellation or suspension (1)
- Designation or determination (1)
Results for
"[search-keyword]"
Sponsor content
150 result(s) found, displaying 101 to 110
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELPHORO sucroferric oxyhydroxide 2500 mg (equivalent to iron 500 mg) chewable tablet blister.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Inactivated quadrivalent influenza vaccine (split virion)
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Seqirus Pty Ltd - Clinical chemistry toxicology/drug detection IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VERSATIS lidocaine (lignocaine) 5% w/w dermal patch.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FERINJECT iron (as ferric carboxymaltose) 100mg/2mL injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FERINJECT iron (as ferric carboxymaltose) 500mg/10mL injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack.